Trial Details
COMPLETEDBasic Information
| Clinical ID | c4231 |
|---|---|
| Identifier | NCT00810030 |
| Trial Title | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Anemia|Iron Deficiency|Iron-Deficiency Anemia|Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: Ferric carboxymaltose|DRUG: Iron Sucrose |
Participant Information
| Sponsor | Vifor Pharma |
|---|---|
| City | Vienna |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2008-10 |
|---|---|
| Primary Completion Date | 2009-12 |
| Completion Date | 2010-04 |